Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets.

[1]  C. Lerk,et al.  Interaction of tablet disintegrants and magnesium stearate during mixing. II. Effect on dissolution rate. , 1982, Pharmaceutica acta Helvetiae.

[2]  P. Sheskey,et al.  Effects of Lubricant Level, Method of Mixing, and Duration of Mixing on a Controlled-Release Matrix Tablet Containing Hydroxypropyl Methylcellulose , 1995 .

[3]  Xueyan Zhao,et al.  AIChE Annual Meeting Conference Proceedings , 2008 .

[4]  Lawrence X. Yu.  Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control , 2008, Pharmaceutical Research.

[5]  P. Pollock,et al.  Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma , 2008, Clinical Cancer Research.

[6]  M. Khan,et al.  Quality by design: impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody. , 2012, International journal of pharmaceutics.

[7]  Ganeshkumar A. Subramanian,et al.  Mechanistic basis for the effects of process parameters on quality attributes in high shear wet granulation. , 2012, International journal of pharmaceutics.

[8]  D. Bindra,et al.  Reversible and pH‐dependent weak drug‐excipient binding does not affect oral bioavailability of high dose drugs , 2012, The Journal of pharmacy and pharmacology.

[9]  J. M. Merritt,et al.  Implementing Quality by Design in Pharmaceutical Salt Selection: A Modeling Approach to Understanding Disproportionation , 2012, Pharmaceutical Research.

[10]  S. Badawy,et al.  Acid-catalyzed hydrolysis of BMS-582664: degradation product identification and mechanism elucidation. , 2012, Journal of pharmaceutical sciences.

[11]  R. Ramachandran,et al.  A combined experimental and modeling approach to study the effects of high-shear wet granulation process parameters on granule characteristics , 2013, Pharmaceutical development and technology.

[12]  Carl Wassgren,et al.  Quality by design for wet granulation in pharmaceutical processing: Assessing models for a priori design and scaling , 2013 .

[13]  P. Pandey,et al.  Processing challenges with solid dosage formulations containing vitamin E TPGS , 2013, Pharmaceutical development and technology.

[14]  J. M. Suñé-Negre,et al.  Quality by Design approach to understand the physicochemical phenomena involved in controlled release of captopril SR matrix tablets. , 2014, International journal of pharmaceutics.

[15]  Ganeshkumar A. Subramanian,et al.  Quality by design development of brivanib alaninate tablets: degradant and moisture control strategy. , 2014, International journal of pharmaceutics.

[16]  R. Kona,et al.  Quality-by-Design III: Application of Near-Infrared Spectroscopy to Monitor Roller Compaction In-process and Product Quality Attributes of Immediate Release Tablets , 2015, AAPS PharmSciTech.

[17]  J. Kushner,et al.  A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes. , 2014, Journal of pharmaceutical sciences.

[18]  G. K. Raju,et al.  Understanding Pharmaceutical Quality by Design , 2014, The AAPS Journal.

[19]  K. Pingali,et al.  Nanosmearing due to process shear - Influence on powder and tablet properties , 2014 .

[20]  Ajit S. Narang,et al.  Addressing Excipient Variability in Formulation Design and Drug Development , 2015 .

[21]  Kevin A. Macias,et al.  Real-time assessment of granule densification in high shear wet granulation and application to scale-up of a placebo and a brivanib alaninate formulation. , 2015, Journal of pharmaceutical sciences.

[22]  S. Badawy,et al.  Role of Self-Association and Supersaturation in Oral Absorption of a Poorly Soluble Weakly Basic Drug , 2015, Pharmaceutical Research.

[23]  J. C. Visser,et al.  Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films. , 2015, International journal of pharmaceutics.